Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44732903

about

Nonalcoholic fatty liver disease as a multi-systemic disease Endocrine causes of nonalcoholic fatty liver disease Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD Role of hemostatic factors in hepatic injury and disease: animal models de-liver.Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.Identification of master genes involved in liver key functions through transcriptomics and epigenomics of methyl donor deficiency in rat: relevance to nonalcoholic liver disease.Idiopathic non-cirrhotic portal hypertension: a review.The future of diagnosing NASH - could a simple blood test be the key?Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis.Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease.Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease.Reply: To PMID 24375485.Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease.Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease.The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification

P2860

Q26749290-51243A55-DA0A-46EA-A4BC-251DCBC3C0BE Q26780254-3226E4B0-C9C5-4BF0-8FC4-E06D696888E2 Q28540257-D81FBD4E-D305-406B-B5A9-A6B0CF5C53E2 Q30274723-7380E790-F33B-4AE7-A9C6-0FC36C4BD1E1 Q30300233-73F88B1A-E552-4FB3-8669-27A13FA339D5 Q31171499-5AD37068-8993-4A91-86E6-578611AD183C Q33877800-607CE6C3-0AFD-4772-A141-D2225F158D97 Q34405039-C3F3FF1B-BD31-4172-8F1F-80A4AA6ED34F Q35113836-1B89BE5A-BDC1-48FF-B747-F4E48FCC254F Q36228033-B589F3CB-DB41-4AAE-8033-D3FC794AD8B5 Q37387653-1135333C-A9CF-4169-B926-96A5969A5DE0 Q37388222-85AD22AB-E31D-4E77-A221-BB3A174EED9B Q37635136-02133CAE-B3FB-4E37-B0B7-325E2903914C Q37681886-42F32962-3934-48A9-89A6-9D5699317134 Q38397177-D8737639-A2A3-4A73-9C1A-C1BD43264FE4 Q38470686-7277493F-78AF-4E48-831E-40741CEF2CFE Q38508108-5D788F70-E585-4756-A741-E73B6F9475E6 Q38634380-6C130656-5C8D-4C1B-9D2E-FCA0B0215A6C Q38808650-8787A3E5-771D-4A70-B5D9-286A75B2F1DB Q40186562-7821C229-7F74-45A6-84E3-670F04B830B4 Q40618944-9BF9F60B-A452-41F9-995F-238B246DEF5A Q45751815-E4AA00A0-D3D9-466A-8879-530BE77F60E2 Q46494101-F114869C-CF72-47A7-86FD-8EE9ED5C70E2 Q46517321-8A541861-5A7B-4B5C-9F73-0BCD8441D75F Q46630941-1BBD76BA-D67C-4F1E-B247-E2D791200EE8 Q49098482-9E408EA8-69C5-472A-BDE0-99ECDAD7B5DE Q50616462-44C462F6-3D9C-494E-A34C-18C7433DBC6C Q51123069-CB0A8B8D-B5CB-4DFB-B5E5-09A17AAE6438 Q51361802-93161DD6-960B-4ACD-BC82-44C4A201E860 Q52791086-FB77F312-64CB-4E04-8B57-0635AAC2957C Q53716936-0A44773C-08A4-4823-BA32-BBB7F571EA4D Q54942348-933AF7AF-6746-4675-947E-D71EE39268E6 Q55342502-93851C50-3D1A-41A4-8A07-218BE6D62732 Q55491214-461ABB07-DE33-44FB-A06B-76E53194DD09 Q58786857-9002B27E-624C-46DC-B426-E1098011864F

P2860

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44732903

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@en

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@nl

type

label

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@en

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@nl

prefLabel

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@en

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@nl

P1433

Q44732903-8B5F54EF-D319-49E0-98BF-CA0B48AA82F6

P1476

Q44732903-28763113-C9AC-4504-96DA-EE1EE7AD7E93

P2093

Q44732903-38DCDAA1-9B95-4EAD-A966-2720F90C7F75

Q44732903-47575FF4-EEDA-45BE-BA87-ABA46EA1414E

Q44732903-8C6DF05F-4A85-4750-A1AA-09368E3CB6A3

Q44732903-92F3575A-FBD9-49CF-B2F6-7942EF61F874

Q44732903-93518BEC-3875-45D4-803E-3CE7A36331A0

Q44732903-B36B095A-19A7-4E56-BF16-045A2F5FB6B7

Q44732903-F2CDFD53-CAD7-4895-B66A-B032479D8ACC

P2860

Q44732903-001B6E84-0371-4FE6-B9BB-E37D5E4ED12E

Q44732903-00AE3DEB-33A6-4233-AA0A-4BDF6C336284

Q44732903-0EF1816E-9BD1-4F90-AC54-0B17D0105886

Q44732903-0F6ABE93-3442-4AF7-BA28-1F28F604E91F

Q44732903-143F33EC-91A3-4B5A-96F1-5D8F305C5CEC

Q44732903-2422D29D-96C9-426A-AB75-20DC8C9D7CBF

Q44732903-2768140E-FE21-4317-9848-9757510008FE

Q44732903-32343F64-E0E0-4A18-B68C-37135F370078

Q44732903-511017F4-60D6-428C-A898-B047C3AD4256

Q44732903-76FDFD56-A657-460E-852E-68F73D0F73D4

P304

Q44732903-F88F48B0-DCAE-47DA-B586-3DA6DEFBF1B5

P31

Q44732903-7550679B-C445-4CF2-B0EB-D8FB38093F0F

P356

Q44732903-26C35420-DD22-45D2-93E7-203B8DCA9B97

P407

Q44732903-9CFCA3FE-9F82-4740-B3B5-8E92F4BBA125

P433

Q44732903-A7B94F00-8467-410A-8E40-5CAAAC070926

P478

Q44732903-2119AD1B-C907-41A5-A506-46AD260475DC

P50

Q44732903-4B392E41-3592-4956-BBF4-253DE8D6FEF6

Q44732903-5DBDE68D-379F-4A95-92C1-87BCBA7AAB9E

Q44732903-93D12DE7-15B8-4E03-8AA2-335400A73F51

P577

Q44732903-D1F13740-DE8B-4686-99ED-6F3CE1A9F8F2

P5875

Q44732903-335ED566-1A00-4C1B-93B0-2C923C0AAA8A

P698

Q44732903-336C8541-900D-4272-A4BF-E6B9E308463B

P921

Q44732903-2FA77842-4F1C-4707-861C-7975702085CA

P356

P1433

P1476

Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.

@en

P2093

An Verrijken

http://www.w3.org/2001/XMLSchema#string

Eric Van Marck

http://www.w3.org/2001/XMLSchema#string

Ilse Mertens

http://www.w3.org/2001/XMLSchema#string

Janne Prawitt

http://www.w3.org/2001/XMLSchema#string

Luc Van Gaal

http://www.w3.org/2001/XMLSchema#string

Sandrine Caron

http://www.w3.org/2001/XMLSchema#string

Sven Francque

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The metabolic syndrome--a new worldwide definition

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications.

Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.

Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.

Obesity, haemostasis and the fibrinolytic system.

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.

P304

121-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26510

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Peter P Michielsen

P577

2013-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259491693

http://www.w3.org/2001/XMLSchema#string

P698

24375485

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis